Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: EGPA, . Treffer: 9
2023
Arnold, S; Mahrhold, J; Kerstein-Staehle, A; Riemekasten, G; Csernok, E; Hellmich, B; Venhoff, N; Thiel, J; Affeldt, K; Jahnke, A; Lamprecht, P
Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.
Clin Exp Rheumatol. 2023; 41(4):936-942
Doi: 10.55563/clinexprheumatol/299yme
PubMed
FullText
FullText_MUG
2021
Canzian, A; Venhoff, N; Urban, ML; Sartorelli, S; Ruppert, AM; Groh, M; Girszyn, N; Taillé, C; Maurier, F; Cottin, V; de, Moreuil, C; Germain, V; Samson, M; Jachiet, M; Denis, L; Rieu, V; Smets, P; Pugnet, G; Deroux, A; Durel, CA; Aouba, A; Cathébras, P; Deligny, C; Faguer, S; Gil, H; Godeau, B; Lifermann, F; Phin-Huynh, S; Ruivard, M; Bonniaud, P; Puéchal, X; Kahn, JE; Thiel, J; Dagna, L; Guillevin, L; Vaglio, A; Emmi, G; Terrier, B, , French, Vasculitis, Study, Group, and, the, European, EGPA, Study, Group
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.
Arthritis Rheumatol. 2021; 73(3): 498-503.
Doi: 10.1002/art.41534
Web of Science
PubMed
FullText
FullText_MUG
Merkt, W; Salzer, U; Thiel, J; Jandova, I; Bergner, R; Venhoff, AC; Venhoff, N
Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides.
BMC Immunol. 2021; 22(1):26
Doi: 10.1186/s12865-021-00416-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Odinius, TO; Buschhorn, L; Wagner, C; Hauch, RT; Dill, V; Dechant, M; Buck, MC; Shoumariyeh, K; Moog, P; Schwaab, J; Reiter, A; Brockow, K; Götze, K; Bassermann, F; Höckendorf, U; Branca, C; Jost, PJ; Jilg, S
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
J CANCER RES CLIN. 2021;
Doi: 10.1007/s00432-021-03827-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Papo, M; Sinico, RA; Teixeira, V; Venhoff, N; Urban, ML; Iudici, M; Mahrhold, J; Locatelli, F; Cassone, G; Schiavon, F; Seeliger, B; Neumann, T; Kroegel, C; Groh, M; Marvisi, C; Samson, M; Barba, T; Jayne, D; Troilo, A; Thiel, J; Hellmich, B; Monti, S; Montecucco, C; Salvarani, C; Kahn, JE; Bonnotte, B; Durel, CA; Puéchal, X; Mouthon, L; Guillevin, L; Emmi, G; Vaglio, A; Terrier, B, , French, Vasculitis, Study, Group, and, the, EGPA, European, Study, Group
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Rheumatology (Oxford). 2021; 60(9): 4355-4360.
Doi: 10.1093/rheumatology/keaa805
Web of Science
PubMed
FullText
FullText_MUG
2017
Thiel, J; Rizzi, M; Engesser, M; Dufner, AK; Troilo, A; Lorenzetti, R; Voll, RE; Venhoff, N
B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients.
ARTHRITIS RES THER. 2017; 19(1): 101
Doi: 10.1186/s13075-017-1306-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Thiel, J; Troilo, A; Salzer, U; Schleyer, T; Halmschlag, K; Rizzi, M; Frede, N; Venhoff, A; Voll, RE; Venhoff, N
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
J ALLER CL IMM-PRACT. 2017; 5(6): 1556-1563.
Doi: 10.1016/j.jaip.2017.07.027
Web of Science
PubMed
FullText
FullText_MUG
2015
Dejaco, C; Oppl, B; Monach, P; Cuthbertson, D; Carette, S; Hoffman, G; Khalidi, N; Koening, C; Langford, C; McKinnon-Maksimowicz, K; Seo, P; Specks, U; Ytterberg, S; Merkel, PA; Zwerina, J
Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
PLoS One. 2015; 10(3):e0121737-e0121737
Doi: 10.1371/journal.pone.0121737
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Thiel, J; Hässler, F; Salzer, U; Voll, RE; Venhoff, N
Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
ARTHRITIS RES THER. 2013; 15(5): R133
Doi: 10.1186/ar4313
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG